Oncology On targeted radiotherapeutics, with Marc Hedrick Dr Marc Hedrick, president and CEO of Plus Therapeutics, discusses developing targeted radiotherapeutics.
News Patient information exposed in breach, says Novo Nordisk Novo Nordisk has become the latest pharma group to be targeted by a cyberattack, confirming a breach exposed some patient data.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
